Literature DB >> 35114419

In Vivo Cardiac-specific Expression of Adenylyl Cyclase 4 Gene Protects against Klotho Deficiency-induced Heart Failure.

Kai Chen1, Shirley Wang1, Zhongjie Sun2.   

Abstract

Klotho is an aging-suppressor gene. Klotho gene deficiency causes heart failure in Klotho-hypomorphic mutant (KL (-/-)) mice. RNA-seq and western blot analysis showed that adenylyl cyclase type IV (AC4) mRNA and protein expression was largely decreased in cardiomyocytes of KL (-/-) mice. The objective of this study was to investigate whether in vivo cardiac-specific expression of AC4 gene protects against Klotho deficiency-induced heart failure. Interestingly, in vivo AAV-based cardiac-specific AC4 gene expression increased left ventricular fractional shortening, ejection fraction, stroke volume, and left ventricular end-diastolic volume in KL (-/-) mice, suggesting that cardiac-specific AC4 gene expression improves Klotho deficiency-induced heart dysfunction. Cardiac-specific AC4 gene expression also decreased Klotho deficiency-induced cardiac hypertrophy. Cardiac-specific AC4 gene expression alleviated Klotho deficiency-induced cardiac fibrosis and calcification. Furthermore, cardiac-specific AC4 gene expression attenuated mitochondrial dysfunction, superoxide accumulation and cardiomyocyte apoptotic cell death. Thus, downregulation of AC4 may contribute to Klotho deficiency-induced heart failure. Mechanistically, AAV2/9-αMHC-AC4 increased cardiomyocytic cAMP levels and thus regulated the PKA-PLN-SERCA2 signal pathway, which is critical in modulating calcium flux and mitochondrial function. In conclusion, cardiac-specific AC4 gene expression protects against Klotho deficiency-induced heart failure through increasing cardiomyocytic cAMP levels, which alleviates cAMP-dependent mitochondrial dysfunction, superoxide accumulation and apoptotic cell death. AC4 regulates superoxide levels via the cAMP-PKA pathway. AC4 could be a potential therapeutic target for heart failure associated with Klotho deficiency. Heart failure is the major cause of mortality in patients with chronic kidney disease (CKD). A decrease in Klotho levels is linked to CKD.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35114419      PMCID: PMC9119924          DOI: 10.1016/j.trsl.2022.01.006

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   10.171


  58 in total

1.  Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage.

Authors:  Yuhong Wang; Zhongjie Sun
Journal:  Hypertension       Date:  2009-07-27       Impact factor: 10.190

2.  Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.

Authors:  Sarah Seiler; Kyrill S Rogacev; Heinz J Roth; Pagah Shafein; Insa Emrich; Stefan Neuhaus; Jürgen Floege; Danilo Fliser; Gunnar H Heine
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 8.237

3.  Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.

Authors:  Ming Chang Hu; Mingjun Shi; Han Jun Cho; Beverley Adams-Huet; Jean Paek; Kathy Hill; John Shelton; Ansel P Amaral; Christian Faul; Masatomo Taniguchi; Myles Wolf; Markus Brand; Masaya Takahashi; Makoto Kuro-O; Joseph A Hill; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2014-10-17       Impact factor: 10.121

4.  Overexpression of adenylyl cyclase type 5 (AC5) confers a proarrhythmic substrate to the heart.

Authors:  Zhenghang Zhao; Gopal J Babu; Hairuo Wen; Nadezhda Fefelova; Richard Gordan; Xiangzhen Sui; Lin Yan; Dorothy E Vatner; Stephen F Vatner; Lai-Hua Xie
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

5.  Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure.

Authors:  N Chin Lai; David M Roth; Mei Hua Gao; Tong Tang; Nancy Dalton; Yin Yin Lai; Matthew Spellman; Paul Clopton; H Kirk Hammond
Journal:  Circulation       Date:  2004-07-12       Impact factor: 29.690

6.  Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart.

Authors:  Jian Xie; Seung-Kuy Cha; Sung-Wan An; Makoto Kuro-O; Lutz Birnbaumer; Chou-Long Huang
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 7.  SERCA2a: a prime target for modulation of cardiac contractility during heart failure.

Authors:  Woo Jin Park; Jae Gyun Oh
Journal:  BMB Rep       Date:  2013-05       Impact factor: 4.778

8.  Cardiac-directed expression of a catalytically inactive adenylyl cyclase 6 protects the heart from sustained β-adrenergic stimulation.

Authors:  Mei Hua Gao; N Chin Lai; Dimosthenis Giamouridis; Young Chul Kim; Tracy Guo; H Kirk Hammond
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

9.  In vivo AAV delivery of glutathione reductase gene attenuates anti-aging gene klotho deficiency-induced kidney damage.

Authors:  Diansa Gao; Shirley Wang; Yi Lin; Zhongjie Sun
Journal:  Redox Biol       Date:  2020-08-20       Impact factor: 11.799

10.  Kidney-Specific Klotho Gene Deletion Causes Aortic Aneurysm via Hyperphosphatemia.

Authors:  Qiongxin Wang; Shirley Wang; Zhongjie Sun
Journal:  Hypertension       Date:  2021-06-28       Impact factor: 9.897

View more
  1 in total

Review 1.  Stem cell therapy for pulmonary arterial hypertension: An update.

Authors:  Qiwei Wilton Sun; Zhongjie Sun
Journal:  J Heart Lung Transplant       Date:  2022-03-06       Impact factor: 13.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.